Clinical Trials Logo

Peptic Ulcer/Erosions clinical trials

View clinical trials related to Peptic Ulcer/Erosions.

Filter by:
  • None
  • Page 1

NCT ID: NCT00843063 Completed - Clinical trials for Peptic Ulcer/Erosions

Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/Erosion

Start date: August 2004
Phase: Phase 4
Study type: Interventional

Low-dose aspirin can prevent cerebral and cardiovascular accidents in individuals with symptomatic atherothrombotic disease, but its use is frequently limited by gastrointestinal side effects. The position of H2-receptor antagonists as a step-down therapy after healing of peptic ulcer or erosions by proton pump inhibitor is unclear. The objective of this randomized, double blinded control study was to compare the efficacy of high-dose famotidine with pantoprazole in the prevention of recurrent dyspeptic or complicated ulcer/ erosions in patients taking low-dose aspirin